Clinical trial
Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Inferior Vena Cava Obstruction With or Without Combined Iliofemoral Obstruction
NCT05409976 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the GORE® VIAFORT Vascular Stent for Treatment of Symptomatic Inferior Vena Cava Obstruction With or Without Combined Iliofemoral Obstruction
- Lead sponsor
- W.L.Gore & Associates
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 25, 2022
- Completion date
- May 9, 2030
- Enrollment
- 136 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
vein disease, vein occlusion, vein thrombosis, venous disease, venous leg ulcer, venous occlusion, venous stasis, venous stenosis, venous thromboses, venous ulcer